Clinical consequences of Aspergillus colonisation and disease in cystic fibrosis and the role of environment in acquisition and infection

Wythenshawe Hospital, Manchester Univaersity NHS Foundation Trust0 个研究点目标入组 110 人开始时间: 2018年3月22日最近更新: 2018年4月30日

适应症

试验速览

暂无简介。

•All patients will have taken part in study REC ref: 07/Q1403/70 between 2008-2011 (number = 129). Surviving patients who have not received a lung transplant or moved away from the unit since that time will be eligible for prospective reclassification of Aspergillus disease. All 129 patients will be followed up for retrospective data.
•1. Cystic fibrosis patients > 18 years old, both male and female
•2. Patients who have taken part in study REC ref: 07/Q1403/70
•3. Patients eligible for reclassification of Aspergillus disease if not undergone lung transplantation or not moved away from area

•1. Non cystic fibrosis patients
•2. Patients not involved in study REC reference number 07/Q1403/70
•3. Patients who have undergone lung transplantation
•4. Patients who have moved away from the area during follow-up time from original study

发起方

Wythenshawe Hospital, Manchester Univaersity NHS Foundation Trust